A Closer Look at Alopecia Areata in Black Patients: Are We Missing Key Diagnostic Clues? Alopecia areata (AA) is more prevalent in patients with skin of color —but how well…
Read More
Hyperpigmentation Patients Report Low Satisfaction and Limited Awareness of Treatment Options A new cross-sectional survey reveals that hyperpigmentation, especially among patients with deeper skin tones, continues to be a significantly…
Read More
Curated by the JDD Editors Missed any of our July highlights? As the official partner of the Skin of Color Update , July is our “Bridging the Gap in Dermatology”…
Read More
Lotion or Cream? A Fresh Look at Moisturizer Efficacy in Dry Skin Dry skin is more than just a nuisance, it’s a clinical challenge that affects comfort, barrier function, and,…
Read More
Catch Up on July’s Latest Case Report on Pincer Nail Relief Pincer nail deformity isn’t just unsightly, it’s painful, persistent, and notoriously difficult to treat. While braces and surgery are…
Read More
June 25 marks World Vitiligo Day, a global recognition of a condition that affects approximately 0.5-2% of the population worldwide. Though non-life-threatening, vitiligo carries a profound psychosocial burden, disproportionately affecting…
Read More
Did you miss it? By 2044, people with skin of color (SOC) will make up the majority of the U.S. population—but dermatology still lags behind in addressing their unique needs.…
Read More
Featured Article Acanthosis nigricans disproportionately affects individuals with darker skin tones, yet no FDA-approved treatment currently exists. As the demand for effective therapies grows, the dermatology community faces a critical challenge:…
Read More
Featured Article Could vitiligo lower melanoma risk—or might it mask it? The intricate relationship between these conditions takes a surprising turn in this compelling case of melanoma on a non-sun-exposed site…
Read More
by Allison Sit Healio wrote about two JDD studies on psoriasis treatments including one on the benefits of long-term ixekizumab. The study, “Benefits Over Five Years of Ixekizumab Treatment in…
Read More
by Allison Sit Managed Healthcare Executive and Healio both wrote about a JDD study on the underrepresentation of racial and ethnic minority groups in vitiligo research. The study, “Racial and…
Read More
by Allison Sit Health Day and Healio wrote about a June JDD study on skin cancer rates in rural areas. The study, “Rural Health Disparities in Skin Cancer Amplified Among…
Read More
